Point72 Asia (Singapore) Pte. Ltd. Cerus Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Cerus Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,342 shares of CERS stock, worth $3,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,342
Previous 14,248
83.56%
Holding current value
$3,981
Previous $26.9 Million
84.69%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
151Shares Held
147MCall Options Held
191KPut Options Held
43.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$33.8 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$33.1 Million0.46% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$23.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$17.8 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$14.6 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $301M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...